When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Absence seizures

Последний просмотренный: 30 Sep 2026
Last updated: 08 Sep 2026

Резюме

Определение

Анамнез и осмотр

Ключевые диагностические факторы

  • family history of childhood seizures
  • staring episode, lasting 5 to 10 seconds; several times per day with no aura/postictal state
  • childhood onset
  • normal physical exam
  • hyperventilation-induced seizure
Полная информация

Другие диагностические факторы

  • automatisms
  • recent decline in school performance
  • early onset (before age 4 years)
Полная информация

Факторы риска

  • family/genetic history of absence epilepsy syndrome
  • acquired brain injury: for example, hypoxia-ischemia, trauma, infection
  • other congenital inborn errors of metabolism, structural defects, chromosomal abnormalities
  • developmental delay or intellectual disability
Полная информация

Диагностические исследования

Исследования, которые показаны в первую очередь

  • EEG
Полная информация

Исследования, проведение которых нужно рассмотреть

  • MRI brain
  • genetic testing
  • testing for metabolic disorders (e.g., serum amino acids, urine organic acids, lactate pyruvate or specific enzymatic tests)
  • cerebrospinal fluid glucose and serum glucose
Полная информация

Алгоритм лечения

Острый

typical absence seizures without a history of generalized tonic-clonic seizures (childhood absence epilepsy)

typical absence seizures with a history of generalized tonic-clonic seizures (CAE, JAE, JME)

atypical absence seizures

ПРОДОЛЖЕНИЕ

refractory to treatment

Составители

Авторы

Emily McGinnis, MD

Clinical Assistant Professor

Department of Clinical Science

Kaiser Permanente Bernard J. Tyson School of Medicine

Los Angeles, CA

Раскрытие информации

EM states that she has no competing interests.

Dean Sarco, MD

Clinical Associate Professor

Department of Clinical Science

Kaiser Permanente Bernard J. Tyson School of Medicine

Los Angeles, CA

Раскрытие информации

DS states that he has no competing interests.

Выражение благодарностей

Dr Emily McGinnis and Dr Dean Sarco would like to gratefully acknowledge Dr Michael Wong and Dr Judith L. Z. Weisenberg, previous contributors to this topic.

Раскрытие информации

MW and JLZW declare that they have no competing interests.

Рецензенты

Dennis Dlugos, MD, MSCE

Professor of Neurology and Pediatrics

Children’s Hospital of Philadelphia

University of Pennsylvania

Pennsylvania, PA

Раскрытие информации

DD states that he has no competing interests.

Anita Devlin, MBBS, MD

Consultant Paediatric Neurologist

Royal Victoria Infirmary

NHS Foundation Trust

Newcastle-upon-Tyne

UK

Раскрытие информации

AD and two epilepsy nurses from her department have been reimbursed by UCB Pharma, the manufacturer of levetiracetam, for attending several conferences. One of the epilepsy nurses received a one-off sponsorship payment from UCB Pharma to cover the initial set-up costs of the adolescent epilepsy support group. One epilepsy nurse has been reimbursed by Cyberonics, the manufacturer of vagal nerve stimulators, for attending one or more conferences.

Helen Cross, MB, ChB, PhD, FRCP, FRCPCH

Head of Neurosciences Unit

The Prince of Wales’s Chair of Childhood Epilepsy

National Centre for Young People with Epilepsy

London

UK

Раскрытие информации

HC has received research funds from HAS, Epilepsy Research UK, SHS, and the Milk Development Council. She has received funding for an epilepsy training fellowship from UCB and Eisai. She has also received travel funding from Eisai, UCB, and GlaxoSmithKline.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Список литературы

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Основные статьи

Beniczky S, Trinka E, Wirrell E, et al. Updated classification of epileptic seizures: position paper of the International League Against Epilepsy. Epilepsia. 2025 Jun;66(6):1804-23.Полный текст  Аннотация

Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology. Epilepsia. 2017 Apr;58(4):512-21.Полный текст  Аннотация

Hirsch E, French J, Scheffer IE, et al. ILAE definition of the idiopathic generalized epilepsy syndromes: position statement by the ILAE task force on nosology and definitions. Epilepsia. 2022 Jun;63(6):1475-99.Полный текст  Аннотация

Specchio N, Wirrell EC, Scheffer IE, et al. International league against epilepsy classification and definition of epilepsy syndromes with onset in childhood: position paper by the ILAE task force on nosology and definitions. Epilepsia. 2022 Jun;63(6):1398-442.Полный текст  Аннотация

Brigo F, Igwe SC, Lattanzi S. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents. Cochrane Database Syst Rev. 2021 Jan 21;1(1):CD003032.Полный текст  Аннотация

Rinaldi VE, Di Cara G, Mencaroni E, et al. Therapeutic options for childhood absence epilepsy. Pediatr Rep. 2021 Dec 16;13(4):658-67.Полный текст  Аннотация

American Academy of Neurology. Practice guideline update summary: efficacy and tolerability of the new antiepileptic drugs I: treatment of new-onset epilepsy. Jun 2018 [internet publication].Полный текст

Статьи, указанные как источники

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

Использование этого контента попадает под действие нашего заявления об отказе от ответственности